Your browser doesn't support javascript.
loading
Characteristics of subjective cognitive decline associated with amyloid positivity.
Janssen, Olin; Jansen, Willemijn J; Vos, Stephanie J B; Boada, Merce; Parnetti, Lucilla; Gabryelewicz, Tomasz; Fladby, Tormod; Molinuevo, José Luis; Villeneuve, Sylvia; Hort, Jakub; Epelbaum, Stéphane; Lleó, Alberto; Engelborghs, Sebastiaan; van der Flier, Wiesje M; Landau, Susan; Popp, Julius; Wallin, Anders; Scheltens, Philip; Rikkert, Marcel Olde; Snyder, Peter J; Rowe, Chris; Chételat, Gaël; Ruíz, Agustin; Marquié, Marta; Chipi, Elena; Wolfsgruber, Steffen; Heneka, Michael; Boecker, Henning; Peters, Oliver; Jarholm, Jonas; Rami, Lorena; Tort-Merino, Adrià; Binette, Alexa Pichet; Poirier, Judes; Rosa-Neto, Pedro; Cerman, Jiri; Dubois, Bruno; Teichmann, Marc; Alcolea, Daniel; Fortea, Juan; Sánchez-Saudinós, M Belén; Ebenau, Jarith; Pocnet, Cornelia; Eckerström, Marie; Thompson, Louisa; Villemagne, Victor; Buckley, Rachel; Burnham, Samantha; Delarue, Marion; Freund-Levi, Yvonne.
Afiliação
  • Janssen O; Alzheimer Centre Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • Jansen WJ; Alzheimer Centre Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • Vos SJB; Alzheimer Centre Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • Boada M; Fundació ACE, Institut Català de Neurociències Aplicades, Facultat de Medicina, Universitat International de Catalunya-Barcelona, Barcelona, Spain.
  • Parnetti L; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
  • Gabryelewicz T; Section of Neurology, Center for Memory Disturbances - Lab. of Clinical Neurochemistry, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Fladby T; Department of Neurodegenerative Disorders, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.
  • Molinuevo JL; Department of Neurology, Akershus University Hospital, Lorenskog, Norway.
  • Villeneuve S; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
  • Hort J; Centre for Studies on Prevention of Alzheimer's Disease (StOP-AD) Centre, Montreal, Quebec, Canada.
  • Epelbaum S; Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
  • Lleó A; International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
  • Engelborghs S; AP-HP, Hôpital de la Pitié Salpêtrière, Institute of Memory and Alzheimer's Disease (IM2A), Centre of excellence of neurodegenerative disease (CoEN), Department of Neurology, Paris, France.
  • van der Flier WM; Inserm Sorbonne Université, Inria, Aramis project-team, Paris Brain Institute - Institut du Cerveau (ICM), Paris, France.
  • Landau S; Neurology Department, Hospital de Sant Pau, Barcelona, Spain.
  • Popp J; Vrije Universiteit Brussel, (VUB) Brussels, and University of Antwerp, Antwerp, Belgium.
  • Wallin A; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Scheltens P; Helen Wills Neuroscience Institute, University of California, Berkeley, California, USA.
  • Rikkert MO; Department of Geriatric Psychiatry, Psychiatric University Hospital, Zürich, Switzerland.
  • Snyder PJ; Old Age Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland.
  • Rowe C; CSIRO Health & Biosecurity, Parkville, Victoria, Australia.
  • Chételat G; Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.
  • Ruíz A; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Marquié M; Department of Geriatric Medicine, Radboud Alzheimer Center, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Chipi E; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Wolfsgruber S; Kingston, The University of Rhode Island, Rhode Island, USA.
  • Heneka M; Department of Molecular Imaging & Therapy, Austin Health, Melbourne, Australia.
  • Boecker H; Institut National de la Sant. et de la Recherche M.dicale (Inserm), Caen, France.
  • Peters O; Fundació ACE, Institut Català de Neurociències Aplicades, Facultat de Medicina, Universitat International de Catalunya-Barcelona, Barcelona, Spain.
  • Jarholm J; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
  • Rami L; Fundació ACE, Institut Català de Neurociències Aplicades, Facultat de Medicina, Universitat International de Catalunya-Barcelona, Barcelona, Spain.
  • Tort-Merino A; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
  • Binette AP; Section of Neurology, Center for Memory Disturbances - Lab. of Clinical Neurochemistry, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Poirier J; German Center For Neurodegenerative Diseases/Clinical Research, Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE), Zentrum für klinische Forschung/AG, Cologne, Germany.
  • Rosa-Neto P; Department of Neurodegenerative Diseases and Psychiatry, University Hospital Bonn, Bonn, Germany.
  • Cerman J; Department of Neurodegenerative Diseases and Psychiatry, University Hospital Bonn, Bonn, Germany.
  • Dubois B; Functional Neuroimaging Group, Department of Radiology, University Hospital Bonn, Bonn, Germany.
  • Teichmann M; Klinik für Psychiatrie und Psychotherapie, Charité Universitätsmedizin Berlin - CBF, Berlin, Deutschland.
  • Alcolea D; Department of Neurology, Akershus University Hospital, Lorenskog, Norway.
  • Fortea J; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
  • Sánchez-Saudinós MB; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
  • Ebenau J; Centre for Studies on Prevention of Alzheimer's Disease (StOP-AD) Centre, Montreal, Quebec, Canada.
  • Pocnet C; Centre for Studies on Prevention of Alzheimer's Disease (StOP-AD) Centre, Montreal, Quebec, Canada.
  • Eckerström M; Centre for Studies on Prevention of Alzheimer's Disease (StOP-AD) Centre, Montreal, Quebec, Canada.
  • Thompson L; Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
  • Villemagne V; International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
  • Buckley R; AP-HP, Hôpital de la Pitié Salpêtrière, Institute of Memory and Alzheimer's Disease (IM2A), Centre of excellence of neurodegenerative disease (CoEN), Department of Neurology, Paris, France.
  • Burnham S; AP-HP, Hôpital de la Pitié Salpêtrière, Institute of Memory and Alzheimer's Disease (IM2A), Centre of excellence of neurodegenerative disease (CoEN), Department of Neurology, Paris, France.
  • Delarue M; Neurology Department, Hospital de Sant Pau, Barcelona, Spain.
  • Freund-Levi Y; Neurology Department, Hospital de Sant Pau, Barcelona, Spain.
Alzheimers Dement ; 18(10): 1832-1845, 2022 10.
Article em En | MEDLINE | ID: mdl-34877782
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Disfunção Cognitiva / Amiloidose Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Alzheimers Dement Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Disfunção Cognitiva / Amiloidose Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Alzheimers Dement Ano de publicação: 2022 Tipo de documento: Article